<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02862496</url>
  </required_header>
  <id_info>
    <org_study_id>2016/345</org_study_id>
    <nct_id>NCT02862496</nct_id>
  </id_info>
  <brief_title>Bone Health in Hyperemesis Gravidarum</brief_title>
  <official_title>Urine N-telopeptide, Serum Vit D, Parathormone and Calcium Levels in Hyperemesis Gravidarum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kayseri Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kayseri Education and Research Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether maternal bone resorption would be seen in
      Hyperemesis Gravidarum and could be detected in early period using serum vitamin D levels,
      serum calcium (Ca) levels, serum parathormone (PTH) levels and urine N- telopeptide levels in
      the patients with Hyperemesis Gravidarum.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>9 Months</target_duration>
  <primary_outcome>
    <measure>Urine N- telopeptide levels in Pregnant Women with Hyperemesis Gravidarum</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Vitamin D Levels in Pregnant Women with Hyperemesis Gravidarum</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Calcium Levels in Pregnant Women with Hyperemesis Gravidarum</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum Parathormone Levels in Pregnant Women with Hyperemesis Gravidarum</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hyperemesis Gravidarum</condition>
  <arm_group>
    <arm_group_label>hyperemesis gravidarum</arm_group_label>
    <description>hyperemesis gravidarum group consisting of 30 pregnant women between 7-20 weeks of gestation with diagnosed hyperemesis gravidarum.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>control group consisting of 30 health pregnant women between 7-20 weeks of gestation with excluded hyperemesis gravidarum.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population was consisted of 2 groups and included pregnant women in between 7.
        and 20. weeks of gestation for both groups. The normal pregnancy group was consisted of 30
        healthy pregnant women whom excluded hyperemesis gravidarum (HG), the HG group was
        consisted of 30 pregnant women with diagnosed HG.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Between 7. and 20. weeks of gestation pregnant women in both groups

          -  İn hyperemesis group; 5% weight loss with regard to pre-gestation vomiting more than 3
             times 3-5 % weight loss with ketonuria.

        Exclusion Criteria:

          -  Other pathologies that cause nausea and vomiting in pregnancy gastroenteritis
             gastroparesis gall duct diseases hepatitis peptic ulcers appendicitis pyelonephritis
             ovarian torsion urinary tract stones diabetic ketoacidosis hyperthyroidism
             hyperparathyroidism migraine pseudo tumor cerebra vestibular diseases

          -  Additionally some situations causing to rise of Ntx levels osteoporosis paget disease
             bone tumors

          -  Furthermore some of conditions resulted in pre-menopausal osteoporosis or decreasing
             in Bone Mineral Density Malignancy Smoking Celiac Disease Depression Inflammatory
             Bowel Disease Pre-gestational Diabetes Chronic Kidney or Liver Disease Drug Use such
             as steroids, anticonvulsants, antiepileptic, heparin or low molecular weight heparin
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erdem SAHİN</last_name>
    <role>Study Director</role>
    <affiliation>Kayseri Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erdem SAHİN, Study Principal İnvestigator</last_name>
    <phone>+905321688683</phone>
    <email>erdemsahin07@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yusuf MADENDAG</last_name>
    <phone>+905055011340</phone>
    <email>yusufmadendag@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kayseri Training and Research Hospital</name>
      <address>
        <city>Kayseri</city>
        <zip>38000</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>5321688683</phone>
      <email>erdemsahin07@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Bailit JL. Hyperemesis gravidarium: Epidemiologic findings from a large cohort. Am J Obstet Gynecol. 2005 Sep;193(3 Pt 1):811-4.</citation>
    <PMID>16150279</PMID>
  </reference>
  <reference>
    <citation>Minami H, Furuhashi M, Minami K, Miyazaki K, Yoshida K, Ishikawa K. Fetal intraventricular bleeding possibly due to maternal vitamin K deficiency. Fetal Diagn Ther. 2008;24(4):357-60. doi: 10.1159/000163078. Epub 2008 Oct 16.</citation>
    <PMID>18931500</PMID>
  </reference>
  <reference>
    <citation>Yahia M, Najeh H, Zied H, Khalaf M, Salah AM, Sofienne BM, Laidi B, Hamed J, Hayenne M. Wernicke's encephalopathy: A rare complication of hyperemesis gravidarum. Anaesth Crit Care Pain Med. 2015 Jun;34(3):173-7. doi: 10.1016/j.accpm.2014.09.005. Epub 2015 May 21.</citation>
    <PMID>26004883</PMID>
  </reference>
  <reference>
    <citation>Practice Bulletin No. 153: Nausea and Vomiting of Pregnancy. Obstet Gynecol. 2015 Sep;126(3):e12-24. doi: 10.1097/AOG.0000000000001048. Review.</citation>
    <PMID>26287788</PMID>
  </reference>
  <reference>
    <citation>Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 1992 Nov;7(11):1251-8.</citation>
    <PMID>1466251</PMID>
  </reference>
  <reference>
    <citation>Hlaing TT, Compston JE. Biochemical markers of bone turnover - uses and limitations. Ann Clin Biochem. 2014 Mar;51(Pt 2):189-202. doi: 10.1177/0004563213515190. Epub 2014 Jan 7. Review.</citation>
    <PMID>24399365</PMID>
  </reference>
  <reference>
    <citation>Sanz-Salvador L, García-Pérez MÁ, Tarín JJ, Cano A. Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture. Eur J Endocrinol. 2015 Feb;172(2):R53-65. doi: 10.1530/EJE-14-0424. Epub 2014 Sep 10. Review.</citation>
    <PMID>25209679</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2016</study_first_submitted>
  <study_first_submitted_qc>August 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>August 7, 2016</last_update_submitted>
  <last_update_submitted_qc>August 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kayseri Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Erdem Sahin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hyperemesis Gravidarum</keyword>
  <keyword>Bone Health</keyword>
  <keyword>Urine N-telopeptide</keyword>
  <keyword>Serum calcium</keyword>
  <keyword>Serum parathormone</keyword>
  <keyword>Serum vit D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperemesis Gravidarum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

